Cargando…

In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites

BACKGROUND: Insulin glargine (Lantus®) is a long-acting basal insulin analog that demonstrates effective day-long glycemic control and a lower incidence of hypoglycemia than NPH insulin. After subcutaneous injection insulin glargine is partly converted into the two main metabolites M1 ([Gly(A21)]ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommerfeld, Mark R., Müller, Günter, Tschank, Georg, Seipke, Gerhard, Habermann, Paul, Kurrle, Roland, Tennagels, Norbert
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832019/
https://www.ncbi.nlm.nih.gov/pubmed/20209060
http://dx.doi.org/10.1371/journal.pone.0009540
_version_ 1782178313768271872
author Sommerfeld, Mark R.
Müller, Günter
Tschank, Georg
Seipke, Gerhard
Habermann, Paul
Kurrle, Roland
Tennagels, Norbert
author_facet Sommerfeld, Mark R.
Müller, Günter
Tschank, Georg
Seipke, Gerhard
Habermann, Paul
Kurrle, Roland
Tennagels, Norbert
author_sort Sommerfeld, Mark R.
collection PubMed
description BACKGROUND: Insulin glargine (Lantus®) is a long-acting basal insulin analog that demonstrates effective day-long glycemic control and a lower incidence of hypoglycemia than NPH insulin. After subcutaneous injection insulin glargine is partly converted into the two main metabolites M1 ([Gly(A21)]insulin) and M2 ([Gly(A21),des-Thr(B30)]insulin). The aim of this study was to characterize the glargine metabolites in vitro with regard to their insulin receptor (IR) and IGF-1 receptor (IGF1R) binding and signaling properties as well as their metabolic and mitogenic activities. METHODS: The affinity of human insulin, insulin glargine and its metabolites to the IR isoforms A and B or IGF1R was analyzed in a competitive binding assay using SPA technology. Receptor autophosphorylation activities were studied via In-Cell Western in CHO and MEF cells overexpressing human IR-A and IR-B or IGF1R, respectively. The metabolic response of the insulins was studied as stimulation of lipid synthesis using primary rat adipocytes. Thymidine incorporation in Saos-2 cells was used to characterize the mitogenic activity. CONCLUSIONS: The binding of insulin glargine and its metabolites M1 and M2 to the IR were similar and correlated well with their corresponding autophosphorylation and metabolic activities in vitro. No differences were found towards the two IR isoforms A or B. Insulin glargine showed a higher affinity for IGF1R than insulin, resulting in a lower EC(50) value for autophosphorylation of the receptor and a more potent stimulation of thymidine incorporation in Saos-2 cells. In contrast, the metabolites M1 and M2 were significantly less active in binding to and activation of the IGF1R and their mitogenicity in Saos-2 cells was equal to human insulin. These findings strongly support the idea that insulin glargine metabolites contribute with the same potency as insulin glargine to blood glucose control but lead to significantly reduced growth-promoting activity.
format Text
id pubmed-2832019
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-28320192010-03-06 In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites Sommerfeld, Mark R. Müller, Günter Tschank, Georg Seipke, Gerhard Habermann, Paul Kurrle, Roland Tennagels, Norbert PLoS One Research Article BACKGROUND: Insulin glargine (Lantus®) is a long-acting basal insulin analog that demonstrates effective day-long glycemic control and a lower incidence of hypoglycemia than NPH insulin. After subcutaneous injection insulin glargine is partly converted into the two main metabolites M1 ([Gly(A21)]insulin) and M2 ([Gly(A21),des-Thr(B30)]insulin). The aim of this study was to characterize the glargine metabolites in vitro with regard to their insulin receptor (IR) and IGF-1 receptor (IGF1R) binding and signaling properties as well as their metabolic and mitogenic activities. METHODS: The affinity of human insulin, insulin glargine and its metabolites to the IR isoforms A and B or IGF1R was analyzed in a competitive binding assay using SPA technology. Receptor autophosphorylation activities were studied via In-Cell Western in CHO and MEF cells overexpressing human IR-A and IR-B or IGF1R, respectively. The metabolic response of the insulins was studied as stimulation of lipid synthesis using primary rat adipocytes. Thymidine incorporation in Saos-2 cells was used to characterize the mitogenic activity. CONCLUSIONS: The binding of insulin glargine and its metabolites M1 and M2 to the IR were similar and correlated well with their corresponding autophosphorylation and metabolic activities in vitro. No differences were found towards the two IR isoforms A or B. Insulin glargine showed a higher affinity for IGF1R than insulin, resulting in a lower EC(50) value for autophosphorylation of the receptor and a more potent stimulation of thymidine incorporation in Saos-2 cells. In contrast, the metabolites M1 and M2 were significantly less active in binding to and activation of the IGF1R and their mitogenicity in Saos-2 cells was equal to human insulin. These findings strongly support the idea that insulin glargine metabolites contribute with the same potency as insulin glargine to blood glucose control but lead to significantly reduced growth-promoting activity. Public Library of Science 2010-03-04 /pmc/articles/PMC2832019/ /pubmed/20209060 http://dx.doi.org/10.1371/journal.pone.0009540 Text en Sommerfeld et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Sommerfeld, Mark R.
Müller, Günter
Tschank, Georg
Seipke, Gerhard
Habermann, Paul
Kurrle, Roland
Tennagels, Norbert
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
title In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
title_full In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
title_fullStr In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
title_full_unstemmed In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
title_short In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
title_sort in vitro metabolic and mitogenic signaling of insulin glargine and its metabolites
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832019/
https://www.ncbi.nlm.nih.gov/pubmed/20209060
http://dx.doi.org/10.1371/journal.pone.0009540
work_keys_str_mv AT sommerfeldmarkr invitrometabolicandmitogenicsignalingofinsulinglargineanditsmetabolites
AT mullergunter invitrometabolicandmitogenicsignalingofinsulinglargineanditsmetabolites
AT tschankgeorg invitrometabolicandmitogenicsignalingofinsulinglargineanditsmetabolites
AT seipkegerhard invitrometabolicandmitogenicsignalingofinsulinglargineanditsmetabolites
AT habermannpaul invitrometabolicandmitogenicsignalingofinsulinglargineanditsmetabolites
AT kurrleroland invitrometabolicandmitogenicsignalingofinsulinglargineanditsmetabolites
AT tennagelsnorbert invitrometabolicandmitogenicsignalingofinsulinglargineanditsmetabolites